Financhill
Back

Crinetics Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$43.44
Seasonality Move:
3.06%

7 Day Trial

ALL ACCESS PASS

$ 7
  • The current trend is moderately bullish and CRNX is experiencing slight selling pressure.

Crinetics Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 44.57 Sell
20-day SMA: 47.56 Sell
50-day SMA: 49.32 Sell
200-day SMA: 38.86 Buy
8-day EMA: 43.54 Sell
20-day EMA: 36.18 Buy
50-day EMA: 21.7 Buy
200-day EMA: 6.83 Buy

Crinetics Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.46 Buy
Relative Strength Index (14 RSI): 36.03 Sell
Chaikin Money Flow: -236157 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.67 - 53.71) Sell
Bollinger Bands (100): (42.06 - 50.54) Sell

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Crinetics Pharmaceuticals, Inc. Stock

Is Crinetics Pharmaceuticals, Inc. Stock a Buy?

CRNX Technical Analysis vs Fundamental Analysis

Sell
6
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy or a Sell?

Crinetics Pharmaceuticals, Inc. Stock Info

Market Cap:
4.5B
Price in USD:
43.44
Share Volume:
930.1K

Crinetics Pharmaceuticals, Inc. 52-Week Range

52-Week High:
57.99
52-Week Low:
24.10
Sell
6
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Crinetics Pharmaceuticals, Inc. Share Price Forecast

Is Crinetics Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Crinetics Pharmaceuticals, Inc.

Is Crinetics Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $1.47 per share.

Technical Analysis of Crinetics Pharmaceuticals, Inc.

Should I short Crinetics Pharmaceuticals, Inc. stock?

* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.